March 10, 2021: Initially, the chemical now identified as Phenethyl-4-Fluoro-4-ANPP was unidentified. As far as we know, this chemical has never before been identified and is 'new in the literature'. The identification of this substance is based on extremely technical expert analytical chemistry. If you are a senior analytical chemist with expertise in fentanyl synthesis, please contact us to let us know what you think about this identification.
For everyone else in the world, we believe Phenethyl-4-Fluoro-4-ANPP is best thought of as a synthesis byproduct of fentanyl, not intentionally included by the manufacturer, that has no pharmacological effect, meaning it doesn't have any effect in humans at this dose level.
However, this identification must be considered tentative until a reference standard is available for us to compare to. We are now publishing this as our tentative identification, although we do not know of any other lab in the world that has identified this substance.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
BTNX Fentanyl Test Strip (prior to sending in sample): Positive
March 10, 2021: Initially, the chemical now identified as Phenethyl-4-Fluoro-4-ANPP was unidentified. As far as we know, this chemical has never before been identified and is 'new in the literature'. The identification of this substance is based on extremely technical expert analytical chemistry. If you are a senior analytical chemist with expertise in fentanyl synthesis, please contact us to let us know what you think about this identification.
For everyone else in the world, we believe Phenethyl-4-Fluoro-4-ANPP is best thought of as a synthesis byproduct of fentanyl, not intentionally included by the manufacturer, that has no pharmacological effect, meaning it doesn't have any effect in humans at this dose level.
However, this identification must be considered tentative until a reference standard is available for us to compare to. We are now publishing this as our tentative identification, although we do not know of any other lab in the world that has identified this substance.